Faron Pharmaceuticals Oy (FARN) — Capital Reinvestment Ratio

Latest as of January 2015: 0.21x

Faron Pharmaceuticals Oy (FARN) has a Capital Reinvestment Ratio of 0.21x as of January 2015, meaning it reinvests 0% of its operating cash flow (GBX178.50) in capital expenditures (GBX38.00). Check tangible net worth ratio of Faron Pharmaceuticals Oy to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.21x
Capex / Operating Cash Flow

Operating Cash Flow

GBX178.50
GBX

Capital Expenditures

GBX38.00
GBX

Data as of

Jan 2015
Most recent filing

Annual Capital Reinvestment Ratio for Faron Pharmaceuticals Oy (None–None)

Year-by-year Capital Reinvestment Ratio for Faron Pharmaceuticals Oy from None to None. See Faron Pharmaceuticals Oy (FARN) free cash flow to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (GBX) Capital Expenditures YoY Change
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow